1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Organ and Tissue Transplantation and Alternative by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Organ and Tissue Transplantation and Alternative by Country/Region, 2018, 2022 & 2029
2.2 Organ and Tissue Transplantation and Alternative Segment by Type
2.2.1 Organ Transplantation
2.2.2 Tissue Transplantation
2.2.3 Cell Transplantation
2.3 Organ and Tissue Transplantation and Alternative Sales by Type
2.3.1 Global Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
2.3.2 Global Organ and Tissue Transplantation and Alternative Revenue and Market Share by Type (2018-2023)
2.3.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Type (2018-2023)
2.4 Organ and Tissue Transplantation and Alternative Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Laboratory
2.5 Organ and Tissue Transplantation and Alternative Sales by Application
2.5.1 Global Organ and Tissue Transplantation and Alternative Sale Market Share by Application (2018-2023)
2.5.2 Global Organ and Tissue Transplantation and Alternative Revenue and Market Share by Application (2018-2023)
2.5.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Application (2018-2023)
3 Global Organ and Tissue Transplantation and Alternative by Company
3.1 Global Organ and Tissue Transplantation and Alternative Breakdown Data by Company
3.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Company (2018-2023)
3.1.2 Global Organ and Tissue Transplantation and Alternative Sales Market Share by Company (2018-2023)
3.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Company (2018-2023)
3.2.1 Global Organ and Tissue Transplantation and Alternative Revenue by Company (2018-2023)
3.2.2 Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Company (2018-2023)
3.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Company
3.4 Key Manufacturers Organ and Tissue Transplantation and Alternative Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Organ and Tissue Transplantation and Alternative Product Location Distribution
3.4.2 Players Organ and Tissue Transplantation and Alternative Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Organ and Tissue Transplantation and Alternative by Geographic Region
4.1 World Historic Organ and Tissue Transplantation and Alternative Market Size by Geographic Region (2018-2023)
4.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Organ and Tissue Transplantation and Alternative Market Size by Country/Region (2018-2023)
4.2.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Country/Region (2018-2023)
4.2.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Country/Region (2018-2023)
4.3 Americas Organ and Tissue Transplantation and Alternative Sales Growth
4.4 APAC Organ and Tissue Transplantation and Alternative Sales Growth
4.5 Europe Organ and Tissue Transplantation and Alternative Sales Growth
4.6 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Growth
5 Americas
5.1 Americas Organ and Tissue Transplantation and Alternative Sales by Country
5.1.1 Americas Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
5.1.2 Americas Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
5.2 Americas Organ and Tissue Transplantation and Alternative Sales by Type
5.3 Americas Organ and Tissue Transplantation and Alternative Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Organ and Tissue Transplantation and Alternative Sales by Region
6.1.1 APAC Organ and Tissue Transplantation and Alternative Sales by Region (2018-2023)
6.1.2 APAC Organ and Tissue Transplantation and Alternative Revenue by Region (2018-2023)
6.2 APAC Organ and Tissue Transplantation and Alternative Sales by Type
6.3 APAC Organ and Tissue Transplantation and Alternative Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Organ and Tissue Transplantation and Alternative by Country
7.1.1 Europe Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
7.1.2 Europe Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
7.2 Europe Organ and Tissue Transplantation and Alternative Sales by Type
7.3 Europe Organ and Tissue Transplantation and Alternative Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Organ and Tissue Transplantation and Alternative by Country
8.1.1 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
8.1.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
8.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Type
8.3 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Organ and Tissue Transplantation and Alternative
10.3 Manufacturing Process Analysis of Organ and Tissue Transplantation and Alternative
10.4 Industry Chain Structure of Organ and Tissue Transplantation and Alternative
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Organ and Tissue Transplantation and Alternative Distributors
11.3 Organ and Tissue Transplantation and Alternative Customer
12 World Forecast Review for Organ and Tissue Transplantation and Alternative by Geographic Region
12.1 Global Organ and Tissue Transplantation and Alternative Market Size Forecast by Region
12.1.1 Global Organ and Tissue Transplantation and Alternative Forecast by Region (2024-2029)
12.1.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Organ and Tissue Transplantation and Alternative Forecast by Type
12.7 Global Organ and Tissue Transplantation and Alternative Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.1.3 Abbott Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Arthrex
13.2.1 Arthrex Company Information
13.2.2 Arthrex Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.2.3 Arthrex Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Arthrex Main Business Overview
13.2.5 Arthrex Latest Developments
13.3 Biomet
13.3.1 Biomet Company Information
13.3.2 Biomet Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.3.3 Biomet Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biomet Main Business Overview
13.3.5 Biomet Latest Developments
13.4 Bristol-Myers
13.4.1 Bristol-Myers Company Information
13.4.2 Bristol-Myers Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.4.3 Bristol-Myers Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bristol-Myers Main Business Overview
13.4.5 Bristol-Myers Latest Developments
13.5 Centacor
13.5.1 Centacor Company Information
13.5.2 Centacor Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.5.3 Centacor Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Centacor Main Business Overview
13.5.5 Centacor Latest Developments
13.6 CryoLife, Inc.
13.6.1 CryoLife, Inc. Company Information
13.6.2 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.6.3 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CryoLife, Inc. Main Business Overview
13.6.5 CryoLife, Inc. Latest Developments
13.7 Dr. Franz Köhler Chemie GmbH
13.7.1 Dr. Franz Köhler Chemie GmbH Company Information
13.7.2 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.7.3 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Franz Köhler Chemie GmbH Main Business Overview
13.7.5 Dr. Franz Köhler Chemie GmbH Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.8.3 Novartis Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Organ Transport Systems
13.9.1 Organ Transport Systems Company Information
13.9.2 Organ Transport Systems Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.9.3 Organ Transport Systems Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Organ Transport Systems Main Business Overview
13.9.5 Organ Transport Systems Latest Developments
13.10 Organogenesis, Inc.
13.10.1 Organogenesis, Inc. Company Information
13.10.2 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.10.3 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Organogenesis, Inc. Main Business Overview
13.10.5 Organogenesis, Inc. Latest Developments
13.11 XVIVO Perfusion AB
13.11.1 XVIVO Perfusion AB Company Information
13.11.2 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.11.3 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 XVIVO Perfusion AB Main Business Overview
13.11.5 XVIVO Perfusion AB Latest Developments
14 Research Findings and Conclusion
臓器/組織移植＆代替品の世界市場2023-2029：臓器移植、組織移植、細胞移植 |
| 【英語タイトル】Global Organ and Tissue Transplantation and Alternative Market Growth 2023-2029 | |
 | ・商品コード：LP23JU2085 ・発行会社（調査会社）：LP Information ・発行日：2023年5月 ・ページ数：104 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ・産業分野：医療装置＆消耗品 |
| Single User（1名様閲覧用） | USD3,660 ⇒換算￥556,320 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,490 ⇒換算￥834,480 | 見積依頼/購入/質問フォーム |
| Corporate User（閲覧人数制限なし） | USD7,320 ⇒換算￥1,112,640 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| LPインフォメーション社の最新調査レポート「臓器/組織移植＆代替品の世界市場」は、過去の販売実績から2022年の世界の臓器/組織移植＆代替品の総販売量を検討し、2023年から2029年の予測される臓器/組織移植＆代替品の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の臓器/組織移植＆代替品の市場規模を掲載し、XXX百万米ドル規模の世界の臓器/組織移植＆代替品市場の詳細な分析を提供します。本インサイトレポートは、世界の臓器/組織移植＆代替品業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の臓器/組織移植＆代替品市場における各社の独自のポジションをより深く理解するために、臓器/組織移植＆代替品製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の臓器/組織移植＆代替品市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。臓器/組織移植＆代替品の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。臓器/組織移植＆代替品の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。臓器/組織移植＆代替品の欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 臓器/組織移植＆代替品の世界主要メーカーとしては、Abbott、 Arthrex、 Biomet、 Bristol-Myers、 Centacor、 CryoLife, Inc.、 Dr. Franz Köhler Chemie GmbH、 Novartis、 Organ Transport Systems、 Organogenesis, Inc.、 XVIVO Perfusion ABなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の臓器/組織移植＆代替品市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では臓器/組織移植＆代替品市場をセグメンテーションし、種類別 (臓器移植、組織移植、細胞移植)、用途別 (病院、診療所、研究室)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：臓器移植、組織移植、細胞移植 ・用途別区分：病院、診療所、研究室 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の臓器/組織移植＆代替品市場の10年間の市場状況・展望は？ ・世界および地域別に見た臓器/組織移植＆代替品市場成長の要因は何か？ ・臓器/組織移植＆代替品の市場機会はエンドマーケットの規模によってどのように変化するのか？ ・臓器/組織移植＆代替品のタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：臓器/組織移植＆代替品の年間販売量2018-2029、地域別現状・将来分析 ・臓器/組織移植＆代替品の種類別セグメント：臓器移植、組織移植、細胞移植 ・臓器/組織移植＆代替品の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・臓器/組織移植＆代替品の用途別セグメント：病院、診療所、研究室 ・臓器/組織移植＆代替品の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の臓器/組織移植＆代替品市場 ・企業別のグローバル臓器/組織移植＆代替品市場データ：2018-2023年の年間販売量、市場シェア ・企業別の臓器/組織移植＆代替品の年間売上：2018-2023年の売上、市場シェア ・企業別の臓器/組織移植＆代替品販売価格 ・主要企業の臓器/組織移植＆代替品生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 臓器/組織移植＆代替品の地域別レビュー ・地域別の臓器/組織移植＆代替品市場規模2018-2023：年間販売量、売上 ・主要国別の臓器/組織移植＆代替品市場規模2018-2023：年間販売量、売上 ・南北アメリカの臓器/組織移植＆代替品販売の成長 ・アジア太平洋の臓器/組織移植＆代替品販売の成長 ・欧州の臓器/組織移植＆代替品販売の成長 ・中東・アフリカの臓器/組織移植＆代替品販売の成長 南北アメリカ市場 ・南北アメリカの国別の臓器/組織移植＆代替品販売量、売上（2018-2023） ・南北アメリカの臓器/組織移植＆代替品の種類別販売量 ・南北アメリカの臓器/組織移植＆代替品の用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の臓器/組織移植＆代替品販売量、売上（2018-2023） ・アジア太平洋の臓器/組織移植＆代替品の種類別販売量 ・アジア太平洋の臓器/組織移植＆代替品の用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の臓器/組織移植＆代替品販売量、売上（2018-2023） ・欧州の臓器/組織移植＆代替品の種類別販売量 ・欧州の臓器/組織移植＆代替品の用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の臓器/組織移植＆代替品販売量、売上（2018-2023） ・中東・アフリカの臓器/組織移植＆代替品の種類別販売量 ・中東・アフリカの臓器/組織移植＆代替品の用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・臓器/組織移植＆代替品の製造コスト構造分析 ・臓器/組織移植＆代替品の製造プロセス分析 ・臓器/組織移植＆代替品の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・臓器/組織移植＆代替品の主要なグローバル販売業者 ・臓器/組織移植＆代替品の主要なグローバル顧客 地域別の臓器/組織移植＆代替品市場予測レビュー ・地域別の臓器/組織移植＆代替品市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・臓器/組織移植＆代替品の種類別市場規模予測 ・臓器/組織移植＆代替品の用途別市場規模予測 主要企業分析 Abbott、 Arthrex、 Biomet、 Bristol-Myers、 Centacor、 CryoLife, Inc.、 Dr. Franz Köhler Chemie GmbH、 Novartis、 Organ Transport Systems、 Organogenesis, Inc.、 XVIVO Perfusion AB ・企業情報 ・臓器/組織移植＆代替品製品 ・臓器/組織移植＆代替品販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
Organ transplantation as a therapeutic strategy for patients with end-stage organ disease have been achieved due to greater insight into the immunobiology of graft rejection and better measures for surgical and medical management.
LPI (LP Information)’ newest research report, the “Organ and Tissue Transplantation and Alternative Industry Forecast” looks at past sales and reviews total world Organ and Tissue Transplantation and Alternative sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ and Tissue Transplantation and Alternative sales for 2023 through 2029. With Organ and Tissue Transplantation and Alternative sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ and Tissue Transplantation and Alternative industry.
This Insight Report provides a comprehensive analysis of the global Organ and Tissue Transplantation and Alternative landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Organ and Tissue Transplantation and Alternative portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ and Tissue Transplantation and Alternative market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ and Tissue Transplantation and Alternative and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ and Tissue Transplantation and Alternative.
The global Organ and Tissue Transplantation and Alternative market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Organ and Tissue Transplantation and Alternative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Organ and Tissue Transplantation and Alternative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Organ and Tissue Transplantation and Alternative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Organ and Tissue Transplantation and Alternative players cover Abbott, Arthrex, Biomet, Bristol-Myers, Centacor, CryoLife, Inc., Dr. Franz Köhler Chemie GmbH, Novartis and Organ Transport Systems, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ and Tissue Transplantation and Alternative market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Organ Transplantation
Tissue Transplantation
Cell Transplantation
Segmentation by application
Hospital
Clinic
Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott
Arthrex
Biomet
Bristol-Myers
Centacor
CryoLife, Inc.
Dr. Franz Köhler Chemie GmbH
Novartis
Organ Transport Systems
Organogenesis, Inc.
XVIVO Perfusion AB
Key Questions Addressed in this Report
What is the 10-year outlook for the global Organ and Tissue Transplantation and Alternative market?
What factors are driving Organ and Tissue Transplantation and Alternative market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Organ and Tissue Transplantation and Alternative market opportunities vary by end market size?
How does Organ and Tissue Transplantation and Alternative break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
❖ レポートの目次 ❖
| ★調査レポート[臓器/組織移植＆代替品の世界市場2023-2029：臓器移植、組織移植、細胞移植] (コード：LP23JU2085)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[臓器/組織移植＆代替品の世界市場2023-2029：臓器移植、組織移植、細胞移植]についてメールでお問い合わせ |
